Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul;20(7):1922-1924.
doi: 10.1111/ajt.15920. Epub 2020 May 8.

Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report

Elisabetta Bussalino  1 , Andrea De Maria  2 , Rodolfo Russo  1 , Ernesto Paoletti  1
Affiliations
Case Reports

Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report

Elisabetta Bussalino et al. Am J Transplant. 2020 Jul.

Abstract

The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2-infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy.

Keywords: clinical research/practice; immunosuppressive regimens; infection and infectious agents-viral; kidney transplantation/nephrology.

PubMed Disclaimer

References

    1. D’Antiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic [published online ahead of print 2020]. Liver Transpl. 2020. 10.1002/lt.25756 - DOI - PubMed
    1. Li LQ, Huang T, Wang YQ, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92:577–583. - PMC - PubMed
    1. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [published online ahead of print 2020]. Intensive Care Med. 2020; 10.1007/s00134-020-05991-x - DOI - PMC - PubMed
    1. Shi Y, Wang Y, Shao C, et al. COVID-19 infection: the perspectives on immune responses [published online ahead of print 2020]. Cell Death Differ. 10.1038/s41418-020-0530-3 - DOI - PMC - PubMed
    1. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. - PMC - PubMed

Publication types

Substances